Phoundry Pharmaceuticals, Inc. — Form D

Phoundry Pharmaceuticals, Inc. of RESEARCH TRIANGLE PARK, NC, a company, filed a Form D exempt-offering notice with the SEC on 2015-08-06. The offering totals $1.0M, of which $500K was reported sold. Industry: Biotechnology.

Offering

Filed: 2015-08-06
Form: D
Accession: 0001650127-15-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $1.0M
Amount sold: $500K
Remaining: $500K
Minimum investment: $50K
Investors: 8
Date of first sale: 2015-07-24
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-245245

Issuer

Name: Phoundry Pharmaceuticals, Inc.
CIK: 0001650127
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2015
Address: 6 Davis Drive, RESEARCH TRIANGLE PARK, NC, 27709
Phone: 919-281-2441

Officers, directors & promoters (10)

Name	Role	Location
Paul L Feldman	Director	Research Triangle Park, NC
Andrew L Young	Director	Research Triangle Park, NC
Paul L Feldman	Executive Officer	Research Triangle Park, NC
Andrew L Young	Executive Officer	Research Triangle Park, NC
Paul L Feldman	Promoter	Research Triangle Park, NC
Mark L Paulik	Promoter	Research Triangle Park, NC
Shane L Roller	Promoter	Research Triangle Park, NC
Ved L Srivastava	Promoter	Research Triangle Park, NC
James L Way	Promoter	Research Triangle Park, NC
Andrew L Young	Promoter	Research Triangle Park, NC

More